ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Nephros Inc

Nephros Inc (NEPH)

1,50
-0,09
(-5,66%)
À la fermeture: 21 Novembre 10:00PM
1,50
0,00
( 0,00% )
Après les heures de négociation: 10:08PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1,50
Prix Achat
0,91
Prix Vente
1,56
Volume échangé
15 301
1,48 Fourchette du Jour 1,598
1,35 Plage de 52 semaines 4,0434
Cap du marché
Clôture Veille
1,59
Ouverture
1,59
Dernière Transaction
8
@
1.52
Dernière heure de transaction
22:00:16
Volume financier
US$ 23 332
VWAP
1,5248
Volume moyen (3 m)
9 977
Actions en circulation
10 544 139
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-10,04
Bénéfice par action (BPA)
-0,15
Chiffre d'affairess
14,24M
Bénéfice net
-1,58M

À propos de Nephros Inc

Nephros Inc is a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets. Nephros Inc is a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets.

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Nephros Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker NEPH. Le dernier cours de clôture d'Nephros était de US$1,59. Au cours de la dernière année, les actions de Nephros ont été négociées dans une fourchette de prix de US$ 1,35 à US$ 4,0434.

Nephros compte actuellement 10 544 139 actions en circulation. La capitalisation boursière d'Nephros est de US$16,77 million. Nephros a un ratio cours/bénéfice (ratio PE) de -10.04.

NEPH Dernières nouvelles

Nephros Announces Financial Results for Quarter Ended September 30, 2024

Third-Quarter Net Revenue of $3.5 Million;Operational Improvements Result In First Profitable Quarter SOUTH ORANGE, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a...

Nephros Schedules Third Quarter 2024 Financial Results Conference Call

SOUTH ORANGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets...

Nephros Launches New HydraGuard 20” UltraFilter

New Filter Targets Additional Industries and Water Quality Compliance SOUTH ORANGE, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced...

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the...

Nephros Announces Financial Results for Quarter Ended June 30, 2024

Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a...

Nephros Schedules Second Quarter 2024 Financial Results Conference Call

SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.12-7.407407407411.621.631.525881.57046603CS
40.128.695652173911.381.66641.3572401.50370458CS
12-0.36-19.35483870971.861.921.3599771.59692425CS
26-0.8499-36.16749648922.34992.41991.35116591.89335641CS
52-0.62-29.24528301892.124.04341.35180152.60732884CS
156-5.94-79.83870967747.447.450.9051300372.1765102CS
260-6.67-81.64014687888.1711.66590.9051230613.43905645CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
VRPXVirpax Pharmaceuticals Inc
US$ 1,10
(86,54%)
8,82M
MTEMMolecular Templates Inc
US$ 0,5749
(51,29%)
11,04M
REPLReplimune Group Inc
US$ 13,14
(18,91%)
157,31k
EYENEyenovia Inc
US$ 0,1243
(18,27%)
3,94M
SKKSKK Holdings Limited
US$ 1,28
(16,36%)
4,32M
CETXCemtrex Inc
US$ 0,1466
(-25,47%)
1,93M
LGTYLogility Supply Chain Solutions Inc
US$ 9,10
(-18,75%)
15,44k
PSWDXtrackers Cybersecurity Select Equity ETF
US$ 27,60
(-18,13%)
122
XTKGX3 Holdings Company Ltd
US$ 0,09
(-16,67%)
353,31k
BTAIBioXcel Therapeutics Inc
US$ 0,4779
(-16,25%)
44,82k
MTEMMolecular Templates Inc
US$ 0,5749
(51,29%)
11,04M
VRPXVirpax Pharmaceuticals Inc
US$ 1,09
(84,84%)
8,82M
ELABElevai Labs Inc
US$ 0,02015
(-0,25%)
5,76M
CDTConduit Pharmaceuticals Inc
US$ 0,0982
(-8,99%)
5,22M
SKKSKK Holdings Limited
US$ 1,28
(16,36%)
4,32M
Aucune Discussion Trouvée
Ajouter une Discussion